Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

[Prognostic significance of serum immunoglobulin paraprotein in chronic lymphocytic leukemia].

Yang S, Zou ZJ, Li YY, Zhang LN, Han TT, Fan L, Xu W, Li JY.

Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):795-800. Chinese.

PMID:
23384896
2.

Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.

Xu W, Wang YH, Fan L, Fang C, Zhu DX, Wang DM, Qiao C, Wu YJ, Li JY.

Leuk Res. 2011 Aug;35(8):1060-5. doi: 10.1016/j.leukres.2010.12.005. Epub 2011 Jan 3.

PMID:
21208658
3.

Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.

Yin CC, Lin P, Carney DA, Handy BC, Rassidakis GZ, Admirand JH, Keating MJ, Medeiros LJ.

Am J Clin Pathol. 2005 Apr;123(4):594-602.

PMID:
15743747
4.

Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.

Zou ZJ, Fan L, Wang L, Zhang R, Zhang LN, Yang S, Li JY, Xu W.

Cancer Biomark. 2012;12(4):169-76. doi: 10.3233/CBM-130304.

PMID:
23568007
5.

[Abnormality of serum immunoglobulin in peripheral blood of patients with chronic lymphocytic leukemia].

Zhu YD, Xu W, Miao KR, Cao X, Fan L, Liu Q, Yao L, Wu YJ, Hong M, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1159-62. Chinese.

PMID:
19840442
6.

Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group.

Shvidel L, Tadmor T, Braester A, Bairey O, Rahimi-Levene N, Herishanu Y, Klepfish A, Ruchlemer R, Berrebi A, Polliack A; Israeli CLL Study Group.

Eur J Haematol. 2014 Jul;93(1):29-33. doi: 10.1111/ejh.12290. Epub 2014 Mar 12.

PMID:
24547751
7.

CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.

Xu W, Li JY, Wu YJ, Yu H, Shen QD, Tian T, Li L, Qiu HX.

Leuk Res. 2009 Feb;33(2):237-43. doi: 10.1016/j.leukres.2008.06.026. Epub 2008 Jul 31.

PMID:
18674817
8.
9.

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, Ostwald M, Busch R, Kuhn-Hallek I, Thiel E, Emmerich B.

Blood. 1999 Mar 1;93(5):1732-7.

10.

Serum paraproteins in chronic lymphocytic leukaemia.

Sinclair D, Dagg JH, Mowat AM, Parrott DM, Stott DI.

J Clin Pathol. 1984 Apr;37(4):463-6.

11.

Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.

Saka B, Aktan M, Sami U, Oner D, Sanem O, Dinçol G.

Clin Lab Haematol. 2006 Feb;28(1):30-5.

PMID:
16430457
12.

CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.

Hock BD, McKenzie JL, McArthur L, Tansley S, Taylor KG, Fernyhough LJ.

Intern Med J. 2010 Dec;40(12):842-9. doi: 10.1111/j.1445-5994.2009.02135.x.

PMID:
20002855
13.

[Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].

González González JB, García Delgado R, Cámara Sáez E, Ortiz Maslloréns F.

Rev Clin Esp. 1996 Aug;196(8):529-35. Spanish.

PMID:
8984539
15.

[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].

Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.

Acta Med Croatica. 2008 Oct;62(4):351-64. Croatian.

PMID:
19205412
16.

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.

Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D.

Blood. 1996 Dec 1;88(11):4259-64.

17.

Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.

Byrd JC, Gribben JG, Peterson BL, Grever MR, Lozanski G, Lucas DM, Lampson B, Larson RA, Caligiuri MA, Heerema NA.

J Clin Oncol. 2006 Jan 20;24(3):437-43. Epub 2005 Dec 12.

PMID:
16344317
18.

The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.

Francis S, Karanth M, Pratt G, Starczynski J, Hooper L, Fegan C, Pepper C, Valcarcel D, Milligan DW, Delgado J.

Cancer. 2006 Sep 1;107(5):1023-33.

19.

Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.

Maurer MJ, Cerhan JR, Katzmann JA, Link BK, Allmer C, Zent CS, Call TG, Rabe KG, Hanson CA, Kay NE, Slager SL, Witzig TE, Shanafelt TD.

Blood. 2011 Sep 8;118(10):2821-6. doi: 10.1182/blood-2011-04-349134. Epub 2011 Jul 15.

20.

Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.

Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.

Eur J Haematol. 2006 Jan;76(1):51-7.

PMID:
16343271

Supplemental Content

Support Center